COVID vaccine response in IBD on different drugs
5-Hydroxytryptophan on fatigue in quiescent IBD
Etrolizumab vs adalimumab in UC
Ustekinumab in CD
Vedolizumab in paediatric IBD
Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in perianal CD
Etrolizumab for maintenance of remission in UC
Infliximab vs conventional therapy in pediatric CD
Lyophilised oral microbiota transplantation for UC
Tofacitinib in UC